immatics biotechnologies GmbH (IMTXW) Ownership

$0.00

south_east
-$0 (-88.46%)
Day's range
$0
Day's range
$0.01

immatics biotechnologies GmbH Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
LMR PARTNERS LLP 08/14/2025 1.34 M $805   0.00% 1.30%
ARISTEIA CAPITAL LLC 08/14/2025 838.88 K $461   0.00% 0.81%
683 CAPITAL MANAGEMENT, LLC 08/14/2025 348.03 K $209   0.00% 0.34%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/14/2025 248.51 K $149   0.00% 0.24%
AFFINITY ASSET ADVISORS, LLC 08/13/2025 187.20 K $112   0.00% 0.18%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2025 77.09 K $414.77 K   0.00% 0.07%
WOLVERINE ASSET MANAGEMENT LLC 08/04/2025 54.38 K $32   -15.53% 0.05%
WEISS ASSET MANAGEMENT LP 08/14/2025 40.07 K $24   0.00% 0.04%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 36.49 K $22   100.00% 0.04%
TORONTO DOMINION BANK 08/14/2025 1.26 K $1   100.00% 0.00%
SPHERA FUNDS MANAGEMENT LTD. 08/14/2025 0 $0   -100.00% 0.00%
UBS GROUP AG 08/14/2025 0 $0   -100.00% 0.00%
AEQUIM ALTERNATIVE INVESTMENTS LP 08/01/2025 0 $0   -100.00% 0.00%

immatics biotechnologies GmbH institutional Ownership - FAQ's

During the previous two years, 12 institutional investors and hedge funds held shares of immatics biotechnologies GmbH. The most heavily invested institutionals were:

LMR Partners LLP: 0

683 Capital Management, LLC: 0

Weiss Asset Management LP: 0

BOOTHBAY FUND MANAGEMENT, LLC: 0

Affinity Asset Advisors, LLC: 0

Nantahala Capital Management, LLC: 0

3.08% of immatics biotechnologies GmbH stock is owned by institutional investors.

Institutional investors have bought a total of 185.43 K shares in the last 24 months. This purchase volume represents approximately $0 in transactions.